Early Prediction of Acute Kidney Injury Among Patients Admitted to Surgical ICU
1 other identifier
interventional
200
1 country
1
Brief Summary
Early prediction of AKI can help to improve patients' outcome through early institution of the appropriate intervention, thus the current study hypothesizes that urine analysis for certain markers may provide an early knowledge about the possibility of oncoming kidney affection secondary to organ and tissue trauma affecting patients admitted to surgical ICU. The current study tries to evaluate the value of urinary markers as early predictors of possible development of AKI in patients admitted to surgical ICU.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 14, 2019
CompletedFirst Submitted
Initial submission to the registry
September 3, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 3, 2020
CompletedFirst Posted
Study publicly available on registry
September 18, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 10, 2020
CompletedMarch 10, 2021
March 1, 2021
12 months
September 3, 2020
March 7, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
The ability of estimated urinary markers for prediction of patients susceptible to develop AKI.
The ability of UNGAL and UKIM1 to early predict acute kidney injury before the serum creatinine rises.
180 days
Secondary Outcomes (2)
The number of patients who developed rise of Serum Creatinine diagnostic of AKI and the extent of AKI severity
180days
The best detector of acute kidney injury
180 days
Study Arms (2)
Urinary human neutrophil gelatinase-associated lipocalin
ACTIVE COMPARATORUrinary human neutrophil gelatinase-associated lipocalin (U-NGAL) measurement
Urinary human kidney injury molecule 1 (U-KIM1)
ACTIVE COMPARATORUrinary human kidney injury molecule 1 (U-KIM1) measurement group
Interventions
enzyme linked immunosorbent assay technology for detection of UNGAL and UKIM1 in urine in postoperative ICU patients
Eligibility Criteria
You may not qualify if:
- Patients with manifest kidney disease.
- Patients had renal surgery
- Patients maintained on renal replacement therapy
- Patients had diabetic nephropathy.
- Patients had liver disease, endocrinopathies.
- Patients morbid obesity that was defined as body mass index (BMI) \>35 kg/m2 .
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tanta Universitylead
Study Sites (1)
Security Forces Hospital
Riyadh, 00966, Saudi Arabia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mohammed Abosamak
Security Forces Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- DIAGNOSTIC
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of anesthesia and intensive care
Study Record Dates
First Submitted
September 3, 2020
First Posted
September 18, 2020
Study Start
September 14, 2019
Primary Completion
September 3, 2020
Study Completion
December 10, 2020
Last Updated
March 10, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL